473 related articles for article (PubMed ID: 11390435)
1. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood.
Jonuleit H; Schmitt E; Stassen M; Tuettenberg A; Knop J; Enk AH
J Exp Med; 2001 Jun; 193(11):1285-94. PubMed ID: 11390435
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood.
Dieckmann D; Plottner H; Berchtold S; Berger T; Schuler G
J Exp Med; 2001 Jun; 193(11):1303-10. PubMed ID: 11390437
[TBL] [Abstract][Full Text] [Related]
3. Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes.
Annunziato F; Cosmi L; Liotta F; Lazzeri E; Manetti R; Vanini V; Romagnani P; Maggi E; Romagnani S
J Exp Med; 2002 Aug; 196(3):379-87. PubMed ID: 12163566
[TBL] [Abstract][Full Text] [Related]
4. Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production.
Bellinghausen I; Klostermann B; Knop J; Saloga J
J Allergy Clin Immunol; 2003 Apr; 111(4):862-8. PubMed ID: 12704370
[TBL] [Abstract][Full Text] [Related]
5. CD4+CD25high regulatory cells in human peripheral blood.
Baecher-Allan C; Brown JA; Freeman GJ; Hafler DA
J Immunol; 2001 Aug; 167(3):1245-53. PubMed ID: 11466340
[TBL] [Abstract][Full Text] [Related]
6. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.
Levings MK; Sangregorio R; Roncarolo MG
J Exp Med; 2001 Jun; 193(11):1295-302. PubMed ID: 11390436
[TBL] [Abstract][Full Text] [Related]
7. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration.
Zhang X; Izikson L; Liu L; Weiner HL
J Immunol; 2001 Oct; 167(8):4245-53. PubMed ID: 11591746
[TBL] [Abstract][Full Text] [Related]
8. A novel costimulation pathway via the 4C8 antigen for the induction of CD4+ regulatory T cells.
Masuyama J; Kaga S; Kano S; Minota S
J Immunol; 2002 Oct; 169(7):3710-6. PubMed ID: 12244164
[TBL] [Abstract][Full Text] [Related]
9. Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance.
Graca L; Thompson S; Lin CY; Adams E; Cobbold SP; Waldmann H
J Immunol; 2002 Jun; 168(11):5558-65. PubMed ID: 12023351
[TBL] [Abstract][Full Text] [Related]
10. Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4+CD25+ regulatory T cells in vivo.
Grundström S; Cederbom L; Sundstedt A; Scheipers P; Ivars F
J Immunol; 2003 May; 170(10):5008-17. PubMed ID: 12734345
[TBL] [Abstract][Full Text] [Related]
11. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.
Takahashi T; Tagami T; Yamazaki S; Uede T; Shimizu J; Sakaguchi N; Mak TW; Sakaguchi S
J Exp Med; 2000 Jul; 192(2):303-10. PubMed ID: 10899917
[TBL] [Abstract][Full Text] [Related]
12. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
[TBL] [Abstract][Full Text] [Related]
13. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade.
Taylor PA; Noelle RJ; Blazar BR
J Exp Med; 2001 Jun; 193(11):1311-8. PubMed ID: 11390438
[TBL] [Abstract][Full Text] [Related]
14. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
Kingsley CI; Karim M; Bushell AR; Wood KJ
J Immunol; 2002 Feb; 168(3):1080-6. PubMed ID: 11801641
[TBL] [Abstract][Full Text] [Related]
15. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.
Levings MK; Sangregorio R; Sartirana C; Moschin AL; Battaglia M; Orban PC; Roncarolo MG
J Exp Med; 2002 Nov; 196(10):1335-46. PubMed ID: 12438424
[TBL] [Abstract][Full Text] [Related]
16. The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4+ CD25- T cells.
Kreijveld E; Koenen HJ; Hilbrands LB; van Hooff HJ; Joosten I
Blood; 2007 Jan; 109(1):244-52. PubMed ID: 16902146
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation.
Read S; Malmström V; Powrie F
J Exp Med; 2000 Jul; 192(2):295-302. PubMed ID: 10899916
[TBL] [Abstract][Full Text] [Related]
18. CD4(+)CD25(+) T cells facilitate the induction of T cell anergy.
Ermann J; Szanya V; Ford GS; Paragas V; Fathman CG; Lejon K
J Immunol; 2001 Oct; 167(8):4271-5. PubMed ID: 11591749
[TBL] [Abstract][Full Text] [Related]
19. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells.
Chen W; Jin W; Wahl SM
J Exp Med; 1998 Nov; 188(10):1849-57. PubMed ID: 9815262
[TBL] [Abstract][Full Text] [Related]
20. Physiological mechanisms of regulating alloimmunity: cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size.
Sho M; Yamada A; Najafian N; Salama AD; Harada H; Sandner SE; Sanchez-Fueyo A; Zheng XX; Strom TB; Sayegh MH
J Immunol; 2002 Oct; 169(7):3744-51. PubMed ID: 12244168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
